Skip to main content

Table 1 Patient characteristics of 63 women with peritoneal cancer undergoing repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin

From: Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer

Patient characteristic Value
Number of patients 63
Age (years; mean ± SD) 62.0 ± 11.3
Previous chemotherapy regimens (median, range) 3 (2–8)
Presence of ascites 35/63 (56.6 %)
Ascites volume (ml; median, range) 150 (10–4500)
PCI (mean ± SD) 17.5 ± 10.0
Serum CA125 (U/ml; mean ± SD) 1590 ± 3753
Primary tumor
 Ovarian cancer 58 (92.1 %)
 Endometrial cancer 3 (4.7 %)
 Pseudomyxoma peritonei 1 (1.6 %)
 Stomach cancer 1 (1.6 %)
Cell type
 Serous papillary adenocarcinoma 37/63 (58.7 %)
 Mucinous adenocarcinoma 2/63 (3.2 %)
 Other 24/63 (38.1 %)
Number of patients sampled at PIPAC 1 and at least one follow-up PIPAC (2, 3, or 4) 42
Number of patients sampled at PIPAC 1, 2 and 3 28
  1. SD standard deviation, PCI Peritoneal Cancer Index